Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
27 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/27/3033826/0/en/Recce-Pharmaceuticals-Granted-Japanese-Patent-for-RECCE-Anti-Infectives.html
19 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/19/3028726/0/en/Recce-Pharmaceuticals-Reports-Positive-Data-from-Phase-II-Trial-of-RECCE-327-Gel-in-Acute-Bacterial-Skin-and-Skin-Structure-Infections-Supporting-Accelerated-Commercialization-Path.html
22 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/22/3013447/0/en/Recce-Pharmaceuticals-Doses-All-Patients-in-Phase-II-Trial-of-RECCE-327-Topical-Gel-in-Acute-Bacterial-Skin-and-Skin-Structure-Infections.html
10 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/10/2994510/0/en/Recce-Pharmaceuticals-Receives-Approval-from-Indonesia-s-Drug-and-Food-Authority-for-Registrational-Phase-3-Trial-of-RECCE-327-Topical-Gel-in-Diabetic-Foot-Infections.html
27 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/27/2988181/0/en/Recce-Pharmaceuticals-Granted-Australia-Patent-for-RECCE-Anti-Infectives.html
12 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/12/2979106/0/en/Recce-Pharmaceuticals-Receives-Ethics-Approval-in-Indonesia-to-Commence-Registrational-Phase-3-Trial-of-RECCE-327-Topical-Gel-in-Diabetic-Foot-Infections.html
ABOUT THIS PAGE